Cigna Group $CI Shares Sold by AMF Tjanstepension AB

AMF Tjanstepension AB cut its holdings in shares of Cigna Group (NYSE:CIFree Report) by 46.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 91,362 shares of the health services provider’s stock after selling 80,168 shares during the period. AMF Tjanstepension AB’s holdings in Cigna Group were worth $26,335,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in CI. Pathway Financial Advisers LLC lifted its holdings in Cigna Group by 2.3% during the 2nd quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider’s stock worth $496,000 after buying an additional 34 shares in the last quarter. Armstrong Advisory Group Inc. grew its stake in shares of Cigna Group by 17.7% in the third quarter. Armstrong Advisory Group Inc. now owns 226 shares of the health services provider’s stock worth $65,000 after acquiring an additional 34 shares in the last quarter. HM Payson & Co. increased its position in shares of Cigna Group by 0.9% during the third quarter. HM Payson & Co. now owns 3,785 shares of the health services provider’s stock worth $1,091,000 after acquiring an additional 35 shares during the period. Carr Financial Group Corp raised its stake in shares of Cigna Group by 5.3% in the third quarter. Carr Financial Group Corp now owns 709 shares of the health services provider’s stock valued at $204,000 after acquiring an additional 36 shares in the last quarter. Finally, Natural Investments LLC boosted its holdings in Cigna Group by 2.0% in the third quarter. Natural Investments LLC now owns 1,843 shares of the health services provider’s stock valued at $531,000 after purchasing an additional 36 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling

In other news, CEO David Cordani acquired 4,134 shares of Cigna Group stock in a transaction on Monday, November 3rd. The stock was bought at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the completion of the purchase, the chief executive officer owned 157,935 shares in the company, valued at $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.70% of the stock is currently owned by company insiders.

Analyst Ratings Changes

CI has been the topic of several recent research reports. JPMorgan Chase & Co. cut their price target on Cigna Group from $428.00 to $375.00 and set an “overweight” rating on the stock in a report on Tuesday, November 4th. Cantor Fitzgerald lowered their price objective on Cigna Group from $365.00 to $325.00 in a research report on Friday, October 31st. Morgan Stanley reaffirmed an “overweight” rating and issued a $355.00 target price on shares of Cigna Group in a report on Friday, October 31st. The Goldman Sachs Group decreased their price target on shares of Cigna Group from $370.00 to $330.00 and set a “buy” rating for the company in a research note on Tuesday, November 4th. Finally, TD Cowen set a $333.00 price objective on shares of Cigna Group in a research report on Monday, December 15th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $330.36.

View Our Latest Report on Cigna Group

Cigna Group Price Performance

Shares of CI opened at $279.31 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.76 and a quick ratio of 0.76. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The stock has a market cap of $74.61 billion, a PE ratio of 12.32, a price-to-earnings-growth ratio of 0.98 and a beta of 0.26. The firm has a fifty day moving average price of $274.46 and a 200 day moving average price of $285.63.

Cigna Group (NYSE:CIGet Free Report) last issued its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The company had revenue of $69.57 billion for the quarter, compared to analyst estimates of $66.40 billion. During the same quarter last year, the company posted $7.51 earnings per share. The business’s quarterly revenue was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, sell-side analysts anticipate that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

See Also

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.